High intensity counselling or behavioural interventions can result in moderate weight loss

Eamonn Slevin DNSc,PG Dip Adv Nursing,BSc,RN (Commentary Author)
{"title":"High intensity counselling or behavioural interventions can result in moderate weight loss","authors":"Eamonn Slevin DNSc,PG Dip Adv Nursing,BSc,RN (Commentary Author)","doi":"10.1016/j.ehbc.2004.03.006","DOIUrl":null,"url":null,"abstract":"<div><h3>Question</h3><p>How effective and safe are screening methods and treatments for obesity?</p></div><div><h3>Study design</h3><p>Systematic review with narrative synthesis.</p></div><div><h3>Main results</h3><p>The review found no RCTs that studied the efficacy of obesity screening. Recent RCTs found that high intensity counselling or behavioural interventions and pharmacological interventions could result in moderate weight loss (see Table 1). The RCTs found that side effects were common (11 to 79%) with pharmacological treatment but not usually serious. Three RCTs found no significant differences in weight loss among different methods of gastric banding surgery (open vs. laparoscopic) or different placements of the gastric band (oesophogastric vs. retrogastric; gastric vs. oesophogastric). All gastric banding groups experienced considerable weight loss (from 17<!--> <!-->kg to over 40<!--> <!-->kg at 1–2 years follow-up). The RCTs did not report on mortality, but one large cohort study of different surgical techniques reported post-operative mortality of 0.2%.<span><div><div><table><tbody><tr><td>Table 1 Summary of outcomes of recent RCTs</td></tr><tr><td>Intervention</td><td>Number RCTs<sup>∗</sup></td><td>RCTs finding significant (<em>P</em>⩽0.05) benefit with intervention</td><td>Mean weight loss difference versus control (kg)<sup>†</sup></td><td>Follow up (months)</td></tr><tr><td><em>Counselling/behavioural</em></td></tr><tr><td>High intensity</td><td>6</td><td>4</td><td>Up to −5.5</td><td>12 to 54</td></tr><tr><td>Moderate intensity</td><td>2</td><td>1</td><td>−0.25 to −3.5</td><td>12 to 18</td></tr><tr><td>Low intensity</td><td>3</td><td>1</td><td>NR</td><td>12 to 36</td></tr><tr><td><em>Pharmacological</em></td></tr><tr><td>Sibutramine</td><td>6</td><td>5</td><td>−2.8 to −7.8</td><td>6 to 12</td></tr><tr><td>Orlistat</td><td>7</td><td>6</td><td>+0.5 to −4.5</td><td>6 to 12.5</td></tr><tr><td>Metformin</td><td>2</td><td>1</td><td>Up to −2.0</td><td>6 to 33.6</td></tr><tr><td><sup>∗</sup>Placebo/no treatment/usual care controlled RCTs not included in previous systematic reviews.</td></tr><tr><td><sup>†</sup>Where reported; NR=not reported</td></tr></tbody></table></div></div></span></p></div><div><h3>Authors’ conclusions</h3><p>Counselling or behavioural interventions and pharmacotherapy can result in moderate weight loss (approximately 3 to 5<!--> <!-->kg) over at least 6–12 months. Pharmacotherapy does have adverse effects. Surgery results in considerable weight loss in very obese people, but there is a risk of mortality.</p></div>","PeriodicalId":100512,"journal":{"name":"Evidence-based Healthcare","volume":"8 3","pages":"Pages 136-138"},"PeriodicalIF":0.0000,"publicationDate":"2004-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ehbc.2004.03.006","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Evidence-based Healthcare","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1462941004000415","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5

Abstract

Question

How effective and safe are screening methods and treatments for obesity?

Study design

Systematic review with narrative synthesis.

Main results

The review found no RCTs that studied the efficacy of obesity screening. Recent RCTs found that high intensity counselling or behavioural interventions and pharmacological interventions could result in moderate weight loss (see Table 1). The RCTs found that side effects were common (11 to 79%) with pharmacological treatment but not usually serious. Three RCTs found no significant differences in weight loss among different methods of gastric banding surgery (open vs. laparoscopic) or different placements of the gastric band (oesophogastric vs. retrogastric; gastric vs. oesophogastric). All gastric banding groups experienced considerable weight loss (from 17 kg to over 40 kg at 1–2 years follow-up). The RCTs did not report on mortality, but one large cohort study of different surgical techniques reported post-operative mortality of 0.2%.

Table 1 Summary of outcomes of recent RCTs
InterventionNumber RCTsRCTs finding significant (P⩽0.05) benefit with interventionMean weight loss difference versus control (kg)Follow up (months)
Counselling/behavioural
High intensity64Up to −5.512 to 54
Moderate intensity21−0.25 to −3.512 to 18
Low intensity31NR12 to 36
Pharmacological
Sibutramine65−2.8 to −7.86 to 12
Orlistat76+0.5 to −4.56 to 12.5
Metformin21Up to −2.06 to 33.6
Placebo/no treatment/usual care controlled RCTs not included in previous systematic reviews.
Where reported; NR=not reported

Authors’ conclusions

Counselling or behavioural interventions and pharmacotherapy can result in moderate weight loss (approximately 3 to 5 kg) over at least 6–12 months. Pharmacotherapy does have adverse effects. Surgery results in considerable weight loss in very obese people, but there is a risk of mortality.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
高强度的咨询或行为干预可导致适度的体重减轻
问题肥胖筛查方法和治疗方法的有效性和安全性如何?研究设计叙事综合的系统回顾。主要结果本综述未发现研究肥胖筛查疗效的随机对照试验。最近的随机对照试验发现,高强度的咨询或行为干预以及药物干预可以导致中度体重减轻(见表1)。随机对照试验发现,药物治疗的副作用很常见(11%至79%),但通常并不严重。三项随机对照试验发现,不同的胃束带手术方法(开放式与腹腔镜)或不同的胃带位置(食管胃束带与胃后束带;胃束带与食管胃束带)在减肥方面没有显著差异。所有胃束带组都经历了相当大的体重减轻(在1-2年的随访中从17公斤减轻到40公斤以上)。随机对照试验没有报告死亡率,但一项针对不同手术技术的大型队列研究报告了0.2%的术后死亡率。表1近期随机对照试验结果摘要干预次数随机对照试验*随机对照试验发现干预有显著(P⩽0.05)益处平均体重减轻差异与对照组(kg)†随访(月)咨询/行为高强度64高达−5.512至54中等强度21−0.25至−3.512至18低强度31NR12至36药理学西布曲明65−2.8至−7.86至12Orlistat76+0.5至−4.56至12.5二甲双胍21至−2.06至33.6*安慰剂/未治疗/常规护理对照随机对照试验未包括在以前的系统综述中。†如有报告;NR=未报告作者的结论咨询或行为干预和药物治疗可在至少6-12个月内导致中度体重减轻(约3-5公斤)。药物治疗确实有不良反应。手术可以显著减轻非常肥胖的人的体重,但也有死亡的风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
High-quality nutrition counselling for hypercholesterolemia by public health nurses in rural areas does not affect total blood cholesterol No association between mobile phone usage and development of acoustic neuroma Retaplase plus abciximab improves non-fatal outcomes, but not overall survival in people with diabetes and acute ST-segment elevation myocardial infarction Intravenous magnesium sulphate does not improve survival or disability outcomes in people with stroke Rate of major complications is higher in laparoscopic than abdominal hysterectomy but quality of life improves with both procedures
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1